Company news

Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

Amgen opens new drug substance facility in North Carolina, US

BIA report: UK biotech investment surged to £3.5bn in 2024

MSD wins FDA priority review for Welireg in rare endocrine cancer

We’re excited to announce that ChemDiv, Inc. will be attending SLAS 2025 in beautiful San Diego, January 25–29!

#BIO2024!
Thank you to everyone who visited us at the ChemDiv, Inc. booth in the California Pavilion.

ChemDiv, Inc. is coming to #BIO2024! Join us at the California Pavilion booth #2625 or connect with us through the Partnering System.

ChemDiv, Inc, announced today that Bill Farley, CEO, will participate in the EF Hutton Annual Global Conference (https://efhutton.com/conference/). The conference is being held in person at Th...

Last week, our team had the incredible opportunity to attend the Annual Meeting of the American Association for Cancer Research (AACR) in San Diego.

Excited for AACR 2024, we invite you to meet our executive team, led by CEO Bill Farley.

Last week, our ChemDiv team, Michael Nyman, Roman Timakhov, and Aleksandra Khotimchenko, had the incredible opportunity to attend the Drug Discovery Chemistry conference in sunny San Diego.

We're thrilled to announce that our team members, Roman Timakhov and Aleksandra Khotimchenko, will be attending the Drug Discovery Chemistry in San Diego, April 1-4.